title: Update on immunotherapy in melanoma.
abstract: Immunotherapy is now recognized as a viable option for patients with metastatic melanoma. The field of immunotherapy now offers treatments with the potential for a long-term cure. As the field moves forward, studies will focus on improving the response rates with new immunotherapy agents or novel treatment combinations.
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Surgery, 1275 York Avenue, New York, NY 10065, USA.
authors.forename: Jamie
authors.initials: J
authors.lastname: Green
authors.affiliation: Memorial Sloan Kettering Cancer Center, Department of Surgery, 1275 York Avenue, New York, NY 10065, USA. Electronic address: ariyanc@mskcc.org.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Ariyan
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D060908:CTLA-4 Antigen / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060908:CTLA-4 Antigen
keywords: Adaptive immunity; Antitumor immunity; Costimulatory blockade; Immunotherapy; Innate immunity; Metastatic melanoma